BIRC7 抗体 (Middle Region)
-
- 抗原 See all BIRC7 抗体
- BIRC7 (Baculoviral IAP Repeat-Containing 7 (BIRC7))
-
抗原表位
- Middle Region
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This BIRC7 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 纯化方法
- Purified
- 免疫原
- BIRC7 antibody was raised in rabbit using the middle region of BIRC7 as the immunogen
- Top Product
- Discover our top product BIRC7 Primary Antibody
-
-
- 应用备注
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - 说明
-
BIRC7 Blocking Peptide, catalog no. 33R-2387, is also available for use as a blocking control in assays to test for specificity of this BIRC7 antibody
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 浓度
- Lot specific
- 缓冲液
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- 注意事项
- Avoid repeated freeze/thaw cycles.
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- 抗原
- BIRC7 (Baculoviral IAP Repeat-Containing 7 (BIRC7))
- 别名
- BIRC7 (BIRC7 产品)
- 背景
- BIRC7 protects against apoptosis induced by TNF or by chemical agents such as adriamycin, etoposide or staurosporine. Suppression of apoptosis is mediated by activation of MAPK8/JNK1, and possibly also of MAPK9/JNK2. This activation depends on TAB1 and NR2C2/TAK1. In vitro, inhibits caspase-3 and proteolytic activation of pro-caspase-9. Isoform 1 blocks staurosporine-induced apoptosis. Isoform 2 blocks etoposide-induced apoptosis. Synonyms: Polyclonal BIRC7 antibody, Anti-BIRC7 antibody, baculoviral IAP repeat-containing 7, livin antibody, KIAP antibody, LIVIN antibody, ML-IAP antibody, MLIAP antibody, RNF50 antibody.
-